All In Biotech

Drug Trial Radar · NCT06436183

A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis

A Phase 2a, Multicenter, Randomized, Double-blind, 16-week Placebo-controlled Study With an Open Label Extension to Evaluate the Efficacy and Safety of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis

Last checked: Nov 19, 2026Latest source record: Sep 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

62

Actual

Start

May 1, 2024

Primary completion

Mar 26, 2025

Study completion Aug 12, 2025

Sponsor

Lead sponsor
Apollo Therapeutics LtdIndustry
Sponsor type
Industry
First posted
May 30, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 2a, multicenter, randomized, double-blind, placebo-controlled study with an open-label extension to evaluate the efficacy and safety of camoteskimab in adults with moderate to severe AD.

Conditions

  • Atopic Dermatitis
  • Atopic
  • Dermatitis
  • Dermatologic Disease
  • Eczema
  • Eczema Atopic Dermatitis
  • Eczema, Atopic

Interventions

  • CamoteskimabDrug

    Drug Product

  • PlaceboDrug

    Inactive substance

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage change from baseline in Eczema Area and Severity Index (EASI) between camoteskimab and placebo at Week 12Time frame: 12 weeks

Locations

35 sites in 2 countries. Site status is shown where the registry gives one.

  • Medical Dermatology Specialists, PC/US Dermatology Partners

    Phoenix, Arizona

  • California Dermatology & Clinical Research Institute

    Encinitas, California

  • First OC Dermatology Research, Inc.

    Fountain Valley, California

  • Center for Dermatology Clinical Research, Inc.

    Fremont, California

  • California Allergy and Asthma Medical Group

    Los Angeles, California

  • University of California Los Angeles Dermatology

    Los Angeles, California

  • Amicis Research Center (Northridge)

    Northridge, California

  • Cura Clinical Research

    Oxnard, California

  • VASDHS - Veterans Affairs San Diego Medical Center

    San Diego, California

  • Clinical Sciences Institute

    Santa Monica, California

  • Renaissance Research and Medical Group

    Cape Coral, Florida

  • D&H National Research Centers, Inc.

    Miami, Florida

  • Avita Clinical Research - Dermatology

    Tampa, Florida

  • Sneeze, Wheeze & Itch Associates, LLC

    Normal, Illinois

  • Dawes Fretzin Clinical Research

    Indianapolis, Indiana

  • Skin Sciences, PLLC

    Louisville, Kentucky

  • Owensboro Dermatology Associates

    Owensboro, Kentucky

  • Revival Research Institute

    Troy, Michigan

  • Somerset Skin Centre

    Troy, Michigan

  • Michigan Dermatology Institute

    Waterford, Michigan

  • Advanced Dermatology and Skin Cancer Center - Saint Joseph

    Saint Joseph, Missouri

  • Skin Specialists PC

    Omaha, Nebraska

  • M3 Wake Research, Inc.

    Raleigh, North Carolina

  • ObjectiveHealth-The Skin Surgery Center for Clinical Research

    Winston-Salem, North Carolina

  • Central Sooner Research

    Oklahoma City, Oklahoma

  • Unity Clinical Research - Dermatology

    Oklahoma City, Oklahoma

  • Paddington Testing Co. Inc

    Philadelphia, Pennsylvania

  • Rodgers Dermatology

    Frisco, Texas

  • Center for Clinical Studies

    Houston, Texas

  • Clinical Trial Network

    Houston, Texas

  • Youthful Image

    Edmonton, Alberta, Canada

  • Rejuvenation Dermatology Clinic Edmonton South

    Edmonton, Alberta, Canada

  • Kingsway Clinical Research

    Etobicoke, Ontario, Canada

  • Clinique Medicale Saint-Louis

    Québec, Quebec, Canada

  • Clinique Dermatologique de Sherbrooke

    Sherbrooke, Quebec, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.